Itochu Technology Ventures, Dai-ichi Life, Saison Ventures, Mizuho Capital and Mitsubishi UFJ Capital have all invested in the medical access app developer.
Japan-based medical treatment app developer CureApp has raised ¥1.5bn ($14.2m) in funding from investors including diversified conglomerate Itochu and its Itochu Technology Ventures unit, The Bridge has reported.
The round also featured life insurance provider Dai-ichi Life as well as Saison Ventures, Mizuho Capital and Mitsubishi UFJ Capital, subsidiaries of payment services provider Credit Saison and financial services firms Mizuho Bank and Mitsubishi UFJ Financial Group.
Venture capital firms Cyberdyne, Chibagin Capital, Beyond Next Ventures (BNV) and Iwagin Jigyo Souzou…
